We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02635945
Recruitment Status : Completed
First Posted : December 21, 2015
Last Update Posted : June 30, 2020
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Hospital de Sant Pau
Information provided by (Responsible Party):
Palobiofarma SL

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 30, 2019
Actual Study Completion Date : November 30, 2019